4BB4basebio UK Societas
465.00GBP+1.09%Mkt Cap: 92.35M $P/E:

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double s…

Key Statistics

Company
Market Cap92.35M $
Enterprise Value90.98M $
Revenue (TTM)2.17M $
Gross Profit1.25M $
Net Income (TTM)-21.68M $
Revenue/Share0.1398 USD
Last Price465.00 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees140
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-7.75
PEG
EV/EBITDA-4.50
EV/Revenue41.90
P/S42.53
P/B7.14
EPS (TTM)-1.09
EPS (Forward)-0.60
52W Range
0.000047% of range1000.00
52W High1000.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin57.53%
Oper. Margin-1604.24%
EBITDA Margin0.00%
Profit Margin-998.52%
ROE-167.19%
ROA-57.21%
Growth
Revenue Growth-14.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-19.99M $
CapEx (TTM)2.10M $
FCF Margin-717.92%
FCF Yield-16.88%
Net Debt-1.70M $
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity1.65
Current Ratio7.31
Quick Ratio6.91
Book Value/Sh0.6510 GBP
Cash/Share1.161 GBP
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBP
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)1600.00 GBP
Upside (mean)+244.1%
Target Range1400.00 GBP1800.00 GBP
GBP1400.00+244.1% to meanGBP1800.00
# Analysts2
Ownership
Shares Out.15.48M
Float5.74M
Insiders60.56%
Institutions14.17%
Technical
SMA 50523.78 (-11.2%)
SMA 200554.75 (-16.2%)
Beta0.87
S&P 52W Chg18.16%
Avg Vol (30d)306
Avg Vol (10d)863
Technical Indicators
RSI (14)26.3
MACD-8.2166
MACD Signal-1.0936
MACD Hist.-7.1230
BB Upper564.51 GBP
BB Middle519.60 GBP
BB Lower474.69 GBP
BB Width17.29%
ATR (14)31.44 GBP
Vol Ratio (20d)4.63x